Daily Bulletin

The Times Real Estate

.

US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG-PR Newswire APAC

SYDNEY, Aug. 7, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Rare Pediatric Disease Designation (RPDD) to Kazia's paxalisib (formerly GDC-0084) for the treatment of...

Read more: US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG-PR Newswire APAC

Business News

How to Estimate the Right Skip Bin Size for Your Renovation Project

One of the most challenging aspects of planning a renovation project is estimating the amount of waste you'll generate. Choosing a skip bin that's too small means paying for additional bins or picku...

Daily Bulletin - avatar Daily Bulletin

Cool Room Hire: The Ultimate Solution for Temperature-Sensitive Storage

Businesses in the food, pharmaceutical, and event industries often require reliable refrigeration to keep products fresh and safe. Cool room hire provides a flexible and cost-effective solution for ...

Daily Bulletin - avatar Daily Bulletin

Thryv Australia named global winner of the 2025 Microsoft Advertising Partner Awards

Melbourne – 11 March 2025:   Thryv® (NASDAQ: THRY), provider of the leading small business marketing and sales software platform, has been named the global winner of the Microsoft Advertising Part...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals